Lecanemab approval in EU: what should we be ready for?– the EANM perspective

Igor Yakushev; Antoine Verger; Matthias Brendel; Diego Cecchin; Pablo Aguiar Fernandez; Francesco Fraioli; Timo Grimmer; Nelleke Tolboom; Tatjana Traub-Weidinger; Eric Guedj; Donatienne Van Weehaeghe

doi:10.1007/s00259-025-07066-9

Lecanemab approval in EU: what should we be ready for?– the EANM perspective

Igor Yakushev^*, Antoine Verger, Matthias Brendel, Diego Cecchin, Pablo Aguiar Fernandez, Francesco Fraioli, Timo Grimmer, Nelleke Tolboom, Tatjana Traub-Weidinger, Eric Guedj, Donatienne Van Weehaeghe

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	1607-1610
Number of pages	4
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	52
Issue number	5
Early online date	10 Jan 2025
DOIs	https://doi.org/10.1007/s00259-025-07066-9
Publication status	Published - Apr 2025

Access to Document

10.1007/s00259-025-07066-9Licence: CC BY

s00259-025-07066-9Final published version, 528 KBLicence: CC BY

Cite this

@article{93fcdec51e2247d091206b99540919a5,

title = "Lecanemab approval in EU: what should we be ready for?– the EANM perspective",

author = "Igor Yakushev and Antoine Verger and Matthias Brendel and Diego Cecchin and Fernandez, {Pablo Aguiar} and Francesco Fraioli and Timo Grimmer and Nelleke Tolboom and Tatjana Traub-Weidinger and Eric Guedj and {Van Weehaeghe}, Donatienne",

year = "2025",

month = apr,

doi = "10.1007/s00259-025-07066-9",

language = "English",

volume = "52",

pages = "1607--1610",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer-Verlag",

number = "5",

}

TY - JOUR

T1 - Lecanemab approval in EU

T2 - what should we be ready for?– the EANM perspective

AU - Yakushev, Igor

AU - Verger, Antoine

AU - Brendel, Matthias

AU - Cecchin, Diego

AU - Fernandez, Pablo Aguiar

AU - Fraioli, Francesco

AU - Grimmer, Timo

AU - Tolboom, Nelleke

AU - Traub-Weidinger, Tatjana

AU - Guedj, Eric

AU - Van Weehaeghe, Donatienne

PY - 2025/4

Y1 - 2025/4

UR - http://www.scopus.com/inward/record.url?scp=85217260341&partnerID=8YFLogxK

U2 - 10.1007/s00259-025-07066-9

DO - 10.1007/s00259-025-07066-9

M3 - Editorial

C2 - 39789225

AN - SCOPUS:85217260341

SN - 1619-7070

VL - 52

SP - 1607

EP - 1610

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - 5

ER -

Lecanemab approval in EU: what should we be ready for?– the EANM perspective

Access to Document

Other files and links

Cite this